[Federal Register Volume 78, Number 54 (Wednesday, March 20, 2013)]
[Notices]
[Pages 17230-17231]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-06321]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances, Notice of Registration, 
Noramco, Inc.

    By Notice dated October 9, 2012, and published in the Federal 
Register on October 18, 2012, 77 FR 64142, Noramco, Inc., 500 Swedes 
Landing Road, Wilmington, Delaware 19801-4417, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of the basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Phenylacetone (8501).......................  II
Opium, raw (9600)..........................  II
Poppy Straw Concentrate (9670).............  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------

    The company plans to import raw Opium (9600) and Poppy Straw 
concentrate (9670) to manufacture other controlled substances. The 
company plans to import Tapentadol (9780) in intermediate form for the 
bulk manufacture of Tapentadol (9780) for distribution to its 
customers. The company plans to import Phenylacetone (8501) in bulk for 
the manufacture of a controlled substance.
    Comments and requests for hearings on applications to import 
narcotic raw

[[Page 17231]]

material are not appropriate. 72 FR 3417 (2007).
    DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and 
determined that the registration of Noramco Inc., to import the basic 
classes of controlled substances is consistent with the public 
interest, and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Noramco, Inc., to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 
1301.34, the above named company is granted registration as an importer 
of the basic classes of controlled substances listed.

    Dated: March 12, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-06321 Filed 3-19-13; 8:45 am]
BILLING CODE 4410-09-P